These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20484197)

  • 41. Combining resynchronization and defibrillation therapies for heart failure.
    Bradley DJ
    JAMA; 2003 May; 289(20):2719-21. PubMed ID: 12771120
    [No Abstract]   [Full Text] [Related]  

  • 42. Frontiers in congestive heart failure: initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Tepper D
    Congest Heart Fail; 2002; 8(2):91. PubMed ID: 11927784
    [No Abstract]   [Full Text] [Related]  

  • 43. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association].
    Mele D; Toselli T; Pratola C; Artale P; Ferrari R
    G Ital Cardiol (Rome); 2007 Dec; 8(12):760-9. PubMed ID: 18085101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale.
    Martin DO; Stolen KQ; Brown S; Yu Y; Christie C; Doshi SK; Smith JM; Gold MR; Day JD
    Am Heart J; 2007 Jan; 153(1):7-13. PubMed ID: 17174627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lead extraction is preferred for lead revisions and system upgrades: when less is more.
    Maytin M; Epstein LM; Henrikson CA
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):413-24; discussion 424. PubMed ID: 20716723
    [No Abstract]   [Full Text] [Related]  

  • 49. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Think before you pull--not every lead has to come out.
    Henrikson CA; Maytin M; Epstein LM
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):409-12; discussion 412. PubMed ID: 20716722
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expansion of heart failure device therapy into a rural indigent population in Louisiana: potential economic and health policy implications.
    Hebert K; McKinnie J; Horswell R; Arcement L; Stevenson L
    J Card Fail; 2006 Dec; 12(9):689-93. PubMed ID: 17174229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The year in heart failure.
    Tang WH; Francis GS
    J Am Coll Cardiol; 2010 Feb; 55(7):688-96. PubMed ID: 20170796
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dear readers].
    Butter C; Israel CW
    Herzschrittmacherther Elektrophysiol; 2008 Dec; 19 Suppl 1():5. PubMed ID: 19169729
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--For].
    Klein HU
    Dtsch Med Wochenschr; 2006 Apr; 131(14):772. PubMed ID: 16596499
    [No Abstract]   [Full Text] [Related]  

  • 56. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.
    Ghanbari H; Hassunizadeh B; Machado C
    Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic heart failure: a comparison between the major guidelines.
    McMurray J; Swedberg K
    Eur Heart J; 2006 Aug; 27(15):1773-7. PubMed ID: 16820365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Device based treatment of heart failure.
    Patwala AY; Wright DJ
    Postgrad Med J; 2005 May; 81(955):286-91. PubMed ID: 15879039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [CRT. ICD. LVAS].
    Wakayama Y; Shiba N; Shirato K
    Nihon Rinsho; 2006 May; 64(5):818-20. PubMed ID: 16689358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.